Combination chemothereapy with cis-diamminedichloroplatinum (II) and bleomycin in tumors of the head and neck

Oncology. 1975;32(5-6):202-7. doi: 10.1159/000225069.

Abstract

28 patients with head and neck tumors not suitable for definitive treatment with radiation or surgery were treated with cis-diamminedichloroplatinum (II) and bleomycin in combination. Of 24 adequately treated patients, there were 3 partial remissions lasting for 3,3 and 6 months, respectively. Toxicity of the regimen as given was substantial; 13 patients showed some evidence of nephrotoxicity and there were 2 drug deaths related to progressive renal failure. 1 patient developed bleomycin pulmonary toxicity.

MeSH terms

  • Acute Kidney Injury / chemically induced
  • Bleomycin / adverse effects
  • Bleomycin / therapeutic use*
  • Cisplatin / adverse effects
  • Cisplatin / therapeutic use
  • Drug Evaluation
  • Drug Therapy, Combination
  • Head and Neck Neoplasms / drug therapy*
  • Hearing Disorders / chemically induced
  • Humans
  • Kidney Diseases / chemically induced
  • Leukocyte Count
  • Lung Diseases / chemically induced
  • Nausea / chemically induced

Substances

  • Bleomycin
  • Cisplatin